[Current view of the prevention of contrast-induced nephropathy].
Ivana
I
Marana
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control; D003287:Contrast Media / Q000009:adverse effects / Q000493:pharmacokinetics; D003404:Creatinine / Q000378:metabolism; D005440:Fluid Therapy / Q000379:methods; D006440:Hemofiltration / Q000379:methods; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000379:methods; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D011322:Primary Prevention / Q000379:methods*; D020011:Protective Agents / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects; D012077:Renal Artery / Q000187:drug effects / Q000503:physiopathology; D018570:Risk Assessment; D012307:Risk Factors
D003287:Contrast Media; D020011:Protective Agents; D003404:Creatinine